<DOC>
	<DOCNO>NCT00833365</DOCNO>
	<brief_summary>The primary objective evaluate Patent Ductus Arteriosus ( PDA ) closure rate early vs. late use Ibuprofen ( Ibu ) . The investigator believe early use Ibu high PDA closure rate later use Ibu . Early use define medication give infant reach 96 hrs old . Late use define medication give infant 96 hr old .</brief_summary>
	<brief_title>Early Versus Late Use Ibuprofen Patent Ductus Arteriosus ( PDA ) Closure</brief_title>
	<detailed_description>Infants birth weight &lt; 1200gm and/or &lt; 28 week gestation diagnose Patent Ductus Arteriosus ( PDA ) qualify study contraindication treatment . Infants randomize treatment arm &lt; 96 hr old &gt; 96 hr old . Ibuprofen give dosage 10 mg/kg initial dose , follow 24 hour later 5 mg/kg dose 24 hour later another dose 5 mg/kg . An echocardiogram do prior treatment within 48 hour treatment .</detailed_description>
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>Birth weight less 1200gm Less 28 week gestational age Confirmed Patent Ductus Arteriosus ( PDA ) via echocardiogram clinical exam Active Bleeding Currently treat Persistent Pulmonary Hypertension ( PPHN ) Cardiac anomalies Chromosomal abnormality Endocrine , metabolic , renal , hepatic disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>96 Hours</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>premature infant</keyword>
	<keyword>PDA</keyword>
	<keyword>ibuprofen</keyword>
</DOC>